These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18451670)

  • 21. Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade.
    de Vinuesa SG; Goicoechea M; Kanter J; Puerta M; Cachofeiro V; Lahera V; Gómez-Campderá F; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S206-12. PubMed ID: 17130263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance in patients with chronic kidney disease.
    Liao MT; Sung CC; Hung KC; Wu CC; Lo L; Lu KC
    J Biomed Biotechnol; 2012; 2012():691369. PubMed ID: 22919275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients.
    Fayed A; El Nokeety MM; Heikal AA; Abdulazim DO; Naguib MM; Sharaf El Din UAA;
    Ren Fail; 2018 Nov; 40(1):226-230. PubMed ID: 29619868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein catabolism in acute renal failure.
    Franz M; Hörl WH
    Miner Electrolyte Metab; 1997; 23(3-6):189-93. PubMed ID: 9387114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance.
    Axelsson J; Bergsten A; Qureshi AR; Heimbürger O; Bárány P; Lönnqvist F; Lindholm B; Nordfors L; Alvestrand A; Stenvinkel P
    Kidney Int; 2006 Feb; 69(3):596-604. PubMed ID: 16395259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
    Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malnutrition and wasting in renal disease.
    Muscaritoli M; Molfino A; Bollea MR; Rossi Fanelli F
    Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):378-83. PubMed ID: 19474712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance and chronic inflammation are associated with muscle wasting in end-stage renal disease patients on hemodialysis.
    Rasić-Milutinović Z; Perunicić-Peković G; Ristić-Medić D; Popović T; Glibetić M; Djurić DM
    Gen Physiol Biophys; 2009; 28 Spec No():184-9. PubMed ID: 19893099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should we quantify insulin resistance in patients with renal disease?
    Shen Y; Peake PW; Kelly JJ
    Nephrology (Carlton); 2005 Dec; 10(6):599-605. PubMed ID: 16354245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of matrix γ-carboxyglutamic acid protein levels with insulin resistance and Lp(a) in diabetes: A cross-sectional study.
    Antonopoulos S; Mylonopoulou M; Angelidi AM; Kousoulis AA; Tentolouris N
    Diabetes Res Clin Pract; 2017 Aug; 130():252-257. PubMed ID: 28654853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Insulin resistance and chronic hepatitis C].
    Tkachenko LI; Maleev VV
    Ter Arkh; 2016; 88(11):29-36. PubMed ID: 28005029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of protein kinetics in chronic renal failure.
    Guarnieri G; Toigo G; Situlin R; Ciocchi B; Biolo G
    Miner Electrolyte Metab; 1997; 23(3-6):214-7. PubMed ID: 9387120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypercatabolism in dialysis patients.
    Raj DS; Sun Y; Tzamaloukas AH
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):589-94. PubMed ID: 18941351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin Resistance and Type 2 Diabetes Mellitus: An Ultimatum to Renal Physiology.
    Sinha S; Haque M
    Cureus; 2022 Sep; 14(9):e28944. PubMed ID: 36111327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
    Stefanović V; Antić S
    Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance in chronic uremia.
    Guarnieri G; Zanetti M; Vinci P; Cattin MR; Barazzoni R
    J Ren Nutr; 2009 Jan; 19(1):20-4. PubMed ID: 19121765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein-energy wasting and nutritional supplementation in patients with end-stage renal disease on hemodialysis.
    Sabatino A; Regolisti G; Karupaiah T; Sahathevan S; Sadu Singh BK; Khor BH; Salhab N; Karavetian M; Cupisti A; Fiaccadori E
    Clin Nutr; 2017 Jun; 36(3):663-671. PubMed ID: 27371993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Insulin resistance and chronic kidney disease].
    Chauveau P; Rigalleau V; Aparicio M
    Nephrol Ther; 2008 Dec; 4(7):568-74. PubMed ID: 18514051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anabolic and catabolic mechanisms in end-stage renal disease.
    Johansen KL
    Adv Chronic Kidney Dis; 2009 Nov; 16(6):501-10. PubMed ID: 19801138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The regulation of muscle protein turnover in diabetes.
    Workeneh B; Bajaj M
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2239-44. PubMed ID: 23838169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.